Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...

Complement System

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Association of ambient air pollution with cognitive functioning and markers of structural brain damage: The Maastricht study.

Environment international·2024

Same author

A global initiative to deliver precision health in diabetes.

Nature medicine·2024

Same author

Accelerometer-derived physical activity and sedentary time and cardiac biomarkers: The Maastricht Study.

Frontiers in cardiovascular medicine·2023

Same author

Cognitive Functioning in Survivors of Hematopoietic Stem Cell Transplantation Compared With a Matched General Population Sample-The Maastricht Observational Study of Late Effects After Stem Cell trAnsplantation Study.

Transplantation and cellular therapy·2023

Same author

In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: A 20-year follow-up in the CARRÉ cohort study.

Seminars in arthritis and rheumatism·2022

Same author

Serum levels of autoantibodies against the angiotensin II type I receptor are not associated with serum dicarbonyl or AGE levels in patients with an aldosterone-producing adenoma.

Journal of human hypertension·2022

Search research articles

Related Experiment Video

Updated: May 25, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Complement C3: an emerging risk factor in cardiometabolic disease.

E Hertle¹, M M J van Greevenbroek, C D A Stehouwer

¹Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.

|January 28, 2012

Summary

Complement component 3 (C3) drives inflammation and metabolic dysfunction, contributing to cardiometabolic disorders like diabetes and atherosclerosis. Targeting C3 may offer new therapeutic strategies for these conditions.

Related Experiment Videos

Last Updated: May 25, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Area of Science:

Immunology
Metabolic Science
Cardiovascular Science

Background:

Complement component 3 (C3) is central to the complement system, mediating inflammatory, immunomodulatory, and metabolic responses.
C3 activation via classical, lectin, or alternative pathways initiates the terminal complement pathway, releasing anaphylatoxin C3a.
C3 is increasingly recognized as a cardiometabolic risk factor, implicated in obesity, dyslipidemia, insulin resistance, and diabetes.

Purpose of the Study:

To elucidate the role of complement C3 in metabolic disorders, vascular complications, and the coagulation system.
To investigate the interaction between C3, diabetes, and the development of atherosclerotic and prothrombotic states.

Main Methods:

Review of epidemiological and experimental evidence linking C3 to cardiometabolic processes.
Analysis of C3 activation pathways and downstream signaling via C3a and C3a-desarg.
Examination of C3's interaction with the coagulation system, including its incorporation into fibrin clots.

Main Results:

C3 activation induces inflammatory and metabolic responses, contributing to conditions like adiposity, dyslipidemia, and insulin resistance.
C3 plays a role in both macrovascular and microvascular complications associated with diabetes.
Evidence suggests C3 interacts with the coagulation system, promoting a prothrombotic state, particularly in diabetes.

Conclusions:

Complement C3 is significantly involved in metabolic, atherosclerotic, and microangiopathic processes.
Further research into complement C3 function and activation is crucial for understanding and treating cardiometabolic disorders.
C3 represents a potential therapeutic target for managing diabetes and its associated vascular complications.